Mallinckrodt agrees $1.6bn opioid settlement with US states

US opioid manufacturer Mallinckrodt has agreed to settle claims from 47 US states and territories. The settlement worth $1.6bn will resolve claims against the company relating to its involvement in the US opioid crisis. The money will be paid over 8 years and will go towards funding treatment for opioid addiction in those states.